1.Polyphenolic Biflavonoids Inhibit Amyloid-Beta Fibrillation and Disaggregate Preformed Amyloid-Beta Fibrils
Erika Y. CHOI ; Sam Sik KANG ; Sang Kook LEE ; Byung Hee HAN
Biomolecules & Therapeutics 2020;28(2):145-151
Alzheimer’s disease (AD) is a devastating neurodegenerative disease and a major cause of dementia in elderly individuals world-wide. Increased deposition of insoluble amyloid β (Aβ) fibrils in the brain is thought be a key neuropathological hallmark of AD. Many recent studies show that natural products such as polyphenolic flavonoids inhibit the formation of insoluble Aβ fibrils and/or destabilize β-sheet-rich Aβ fibrils to form non-cytotoxic aggregates. In the present study, we explored the structure-activity relationship of naturally-occurring biflavonoids on Aβ amyloidogenesis utilizing an in vitro thioflavin T assay with Aβ1–42 peptide which is prone to aggregate more rapidly to fibrils than Aβ1–40 peptide. Among the biflavonoids we tested, we found amentoflavone revealed the most potent effects on inhibiting Aβ1–42 fibrillization (IC50: 0.26 μM), as well as on disassembling preformed Aβ1–42 fibrils (EC50: 0.59 μM). Our structure-activity relationship study suggests that the hydroxyl groups of biflavonoid compounds play an essential role in their molecular interaction with the dynamic process of Aβ1–42 fibrillization. Our atomic force microscopic imaging analysis demonstrates that amentoflavone directly disrupts the fibrillar structure of preformed Aβ1–42 fibrils, resulting in conversion of those fibrils to amorphous Aβ1–42 aggregates. These results indicate that amentoflavone affords the most potent anti-amyloidogenic effects on both inhibition of Aβ1–42 fibrillization and disaggregation of preformed mature Aβ1–42 fibrils.
2.Spontaneous Disappearance of an Arachnoid Cyst after Burr Hole Drainage of Chronic Subdural Hematoma
Do Yub KIM ; Sungjoon LEE ; Byung Sam CHOI ; Jung Soo KIM
Korean Journal of Neurotrauma 2019;15(2):159-163
It is well known that the presence of arachnoid cysts (ACs) in young patients is a risk factor for developing a chronic subdural hematoma (CSDH) after a minor head injury. Although there have been controversies with the treatment, most authors recommend only draining the CSDH if the AC is asymptomatic. This judgement is based on the facts that this surgical approach has shown good clinical outcomes, and the AC usually remains unchanged after the surgery. Our case demonstrates that the AC of a young patient who developed a CSDH after a minor head injury completely disappeared after a burr hole drainage of the CSDH. Although the chances of an AC disappearing are low, this case shows that an AC might disappear after only draining a CSDH when a rupture of the AC membrane is identified. In such cases, we recommend first draining only the CSDH for the treatment of AC-associated CSDHs.
Arachnoid Cysts
;
Arachnoid
;
Craniocerebral Trauma
;
Drainage
;
Hematoma, Subdural, Chronic
;
Humans
;
Membranes
;
Risk Factors
;
Rupture
3.Recurrence of Small Cerebral Aneurysms (< 4 mm) Treated Endovascularly Using Target® Nano™ Coils.
Sung Min KIM ; Hyun Gon LEE ; Byung Sam CHOI ; Jung Soo KIM ; Sung Joon LEE ; Hae Yu KIM ; Sung Tae KIM ; Young Gyun JEONG ; Jin Wook BAEK ; Hae Woong JEONG ; Sung Chul JIN
Journal of Cerebrovascular and Endovascular Neurosurgery 2018;20(2):106-111
OBJECTIVE: In our series, endovascular coiling with Target® Nano™ coils (Stryker Neurovascular, Fremont, CA, USA) with diameters of 1 or 1.5 mm exhibited favorable technical feasibility in the treatment of small cerebral aneurysms (< 4 mm). However, little is known about the recurrence of small cerebral aneurysms treated using Target® Nano™ coils. We investigated recurrence following the treatment of small cerebral aneurysms using Target® Nano™ coils. MATERIALS AND METHODS: Between January 2012 and November 2013, 143 patients with 148 small cerebral aneurysms (< 4 mm) were included our study. A total of 135 cerebral aneurysms (91.2%) were unruptured; 45 cerebral aneurysms (30.4%) were treated by endovascular coiling using Target® Nano™ coils. Follow-up radiological images were obtained for 132 cerebral aneurysms (89.2%) over a range of 3 to 58 months (mean, 34.3 months; standard deviation, 14.2). RESULTS: In the group treated with Target® Nano™ coils, radiological outcomes revealed complete occlusion in 33 (73.3%), residual necks in eight (17.8%), and residual sacs in four (8.9%) cases. Follow-up radiological outcomes revealed complete occlusion in 35 (77.8%) and residual necks in four (8.9%) cases that exhibited stable coil masses. In the group that was not treated with Target® Nano™ coils, radiological outcomes revealed complete occlusion in 69 (67%), residual necks in 18 (17.5%), and residual sacs in 16 (15.5%) cases. Follow-up radiological outcomes revealed complete occlusion in 87 (84.5%) and residual necks (5.8%) in six cases that exhibited stable coil masses. No significant differences were observed in the radiological outcomes or follow-up radiological outcomes between the two groups. No recurrences or retreatments occurred in our series. CONCLUSION: Endovascular treatment using Target® Nano™ coils may be a robust treatment option for small cerebral aneurysms (< 4 mm).
Follow-Up Studies
;
Humans
;
Intracranial Aneurysm*
;
Neck
;
Recurrence*
;
Retreatment
4.Minimum Measurement Time Affecting the Reliability of the Heart Rate Variability Analysis.
Won Jun CHOI ; Byung Chae LEE ; Kee Sam JEONG ; Yong Jae LEE
Korean Journal of Health Promotion 2017;17(4):269-274
BACKGROUND: Heart rate variability (HRV) test is in widely used for measurement of autonomic nerve system. Although the standard measurement time for short-term HRV analysis is regarded as 5 minutes, it could be varied depending on the clinical situation. Thus, we examined that the valid minimum measurement time for HRV through comparison of HRV among 10 segments per 30 seconds from 30 seconds to 300 seconds. METHODS: The study included 1,457 adult participants who visited the health promotion center in Seoul, Korea from the March 2009 to December 2012. The variables of the time domain and frequency domain analysis of HRV among 10 segments from 30 seconds to 300 seconds were compared using one-way ANOVA test with post-hoc analysis. RESULTS: Compared with 5-minute (300 seconds) HRV, the components of HRV measurement were statistically equal in condition with 180 seconds for standard deviation of all normal-to-normal interval (SDNN), 270 seconds for NN50, 180 seconds for total power, 180 seconds for low frequency power in normalized units (LFn), and 180 seconds for high frequency power in normalized units (HFn), respectively. CONCLUSIONS: Our results suggest that the minimum duration of HRV measurement might be more or than 180 seconds.
Adult
;
Autonomic Nervous System
;
Autonomic Pathways
;
Health Promotion
;
Heart Rate*
;
Heart*
;
Humans
;
Korea
;
Seoul
5.MUC Expression in Gallbladder Epithelial Tissues in Cholesterol-Associated Gallbladder Disease.
Kyo Sang YOO ; Ho Soon CHOI ; Dae Won JUN ; Hang Lak LEE ; Oh Young LEE ; Byung Chul YOON ; Kyeong Geun LEE ; Seung Sam PAIK ; Yong Seok KIM ; Jin LEE
Gut and Liver 2016;10(5):851-858
BACKGROUND/AIMS: Gallstone pathogenesis is linked to mucin hypersecretion and bacterial infection. Several mucin genes have been identified in gallbladder epithelial cells (GBECs). We investigated MUC expression in cholesterol-associated gallbladder disease and evaluated the relationship between mucin and bacterial infection. METHODS: The present study involved 20 patients with cholesterol stones with cholecystitis, five with cholesterol stones with cholesterolosis, six with cholesterol polyps, two with gallbladder cancer, and six controls. Canine GBECs treated with lipopolysaccharide were also studied. MUC3, MUC5AC, MUC5B, and MUC6 antibodies were used for dot/slot immunoblotting and immunohistochemical studies of the gallbladder epithelial tissues, canine GBECs, and bile. Reverse-transcription polymerase chain reaction was performed to evaluate MUC3 and MUC5B expression. RESULTS: MUC3, MUC5AC, MUC5B, and MUC6 were expressed in the normal gallbladder epithelium, and of those, MUC3 and MUC5B exhibited the highest expression levels. Greatly increased levels of MUC3 and MUC5B expression were observed in the cholesterol stone group, and slightly increased levels were observed in the cholesterol polyp group; MUC3 and MUC5B mRNA was also upregulated in those groups. Canine GBECs treated with lipopolysaccharide also showed upregulation of MUC3 and MUC5B. CONCLUSIONS: The mucin genes with the highest expression levels in gallbladder tissue in cholesterol-associated diseases were MUC3 and MUC5B. Cholesterol stones and gallbladder infections were associated with increased MUC3 and MUC5B expression.
Antibodies
;
Bacterial Infections
;
Bile
;
Cholecystitis
;
Cholesterol
;
Epithelial Cells
;
Epithelium
;
Gallbladder Diseases*
;
Gallbladder Neoplasms
;
Gallbladder*
;
Gallstones
;
Humans
;
Immunoblotting
;
Mucins
;
Polymerase Chain Reaction
;
Polyps
;
RNA, Messenger
;
Up-Regulation
6.Incarcerated umbilical hernia with small bowel obstruction in a continuous ambulatory peritoneal dialysis patient.
Yo Han JEONG ; Jun Young DO ; Mun Ju HWANG ; Min Jung KIM ; Min Geun GU ; Byung Sam PARK ; Jung Eun CHOI ; Tae Woo KIM
Yeungnam University Journal of Medicine 2014;31(1):25-27
Patients treated with peritoneal dialysis have increased intra-abdominal pressure and a high prevalence of abdominal wall complications. Hernias can lead to significant morbidity in patients on peritoneal dialysis. Hernias are clinically important because of the risk of incarceration, strangulation and subsequent bowel obstruction, rupture, and peritonitis. In this paper, a case of incarcerated umbilical hernia with small bowel obstruction in a continuous ambulatory peritoneal dialysis (CAPD) patient is reported. The small bowel obstruction improved after herniorrhaphy, and the peritoneal dialysis was resumed 2 weeks after the herniorrhaphy. The patient had been undergoing CAPD without technical failure until the 2 months follow-up after the herniorrhaphy. This case shows that early detection of incarcerated umbilical hernia and herniorrhaphy can prevent resection of a strangulated small bowel so that it can remain on CAPD without post-operative technical failure. Umbilical hernias should be carefully observed and intestinal obstruction should be considered when a CAPD patient with an umbilical hernia has abdominal pain.
Abdominal Pain
;
Abdominal Wall
;
Follow-Up Studies
;
Hernia
;
Hernia, Umbilical*
;
Herniorrhaphy
;
Humans
;
Intestinal Obstruction
;
Peritoneal Dialysis
;
Peritoneal Dialysis, Continuous Ambulatory*
;
Peritonitis
;
Prevalence
;
Rupture
7.Stricture Occurring after Endoscopic Submucosal Dissection for Esophageal and Gastric Tumors.
Gwang Ha KIM ; Sam Ryong JEE ; Jae Young JANG ; Sung Kwan SHIN ; Kee Don CHOI ; Jun Haeng LEE ; Sang Gyun KIM ; Jae Kyu SUNG ; Suck Chei CHOI ; Seong Woo JEON ; Byung Ik JANG ; Kyu Chan HUH ; Dong Kyung CHANG ; Sung Ae JUNG ; Bora KEUM ; Jin Woong CHO ; Il Ju CHOI ; Hwoon Yong JUNG
Clinical Endoscopy 2014;47(6):516-522
Endoscopic submucosal dissection (ESD) is a widely accepted treatment for early gastric and esophageal cancer. Compared to endoscopic mucosal resection, ESD has the advantage of enabling en bloc removal of tumors regardless of their size. However, ESD can result in a large artificial ulcer, which may lead to a considerable deformity. Circumferential mucosal defects of more than three-fourths the esophageal circumference, long longitudinal mucosal defects (>30 mm), and lesions in the upper esophagus are significant risk factors for the development of post-ESD strictures of the esophagus. In the stomach, a circumferential mucosal defects more than three-fourths in extent and longitudinal mucosal defects >5 cm are risk factors of post-ESD stricture. If scheduled early, regular endoscopic balloon dilation is effective in controlling and preventing post-ESD stricture. Moreover, intralesional steroid injections or oral steroids can achieve remission of dysphagia or reduce the need for repeated endoscopic balloon dilation. However, further study is needed to improve the prevention of stricture formation.
Congenital Abnormalities
;
Constriction, Pathologic*
;
Deglutition Disorders
;
Esophageal Neoplasms
;
Esophagus
;
Risk Factors
;
Steroids
;
Stomach
;
Ulcer
8.A Case of Malignant Granular Cell Tumor in the Sigmoid Colon.
Sang Myung CHOI ; Seung Goun HONG ; Shin Myung KANG ; Byung Gi CHAE ; Sung Jin KIM ; Pyung Kang PARK ; Hyun Sung PARK
Clinical Endoscopy 2014;47(2):197-200
Granular cell tumor (GCT) is an uncommon, usually benign neoplasm; however, a malignant potential has been described. Malignant GCT is an extremely rare neoplasm showing rapid growth and invasion into adjacent muscles, lymph nodes, or vessels, or even distant metastasis. We recently experienced a case of a histologically benign or atypical but clinically malignant GCT, with invasion of the lymph nodes and vessels in the sigmoid colon, diagnosed by segmental colon resection with lymph node dissection. We also performed a review of relevant medical literature.
Colon
;
Colon, Sigmoid*
;
Granular Cell Tumor*
;
Lymph Node Excision
;
Lymph Nodes
;
Muscles
;
Neoplasm Metastasis
9.Guidelines for the Treatment of Functional Dyspepsia.
Sam Ryong JEE ; Hye Kyung JUNG ; Byung Hoon MIN ; Kee Don CHOI ; Poong Lyul RHEE ; Young Woo KANG ; Sang In LEE
The Korean Journal of Gastroenterology 2011;57(2):67-81
Functional dyspepsia (FD) is defined as the presence of symptoms thought to originate in the gastroduodenal area, in the absence of any organic, systemic, or metabolic disease that is likely to explain the symptoms. Based on the available evidence and consensus opinion, thirteen consensus statements for the treatment of FD were developed using the modified Delphi approach. Proton pump inhibitor, prokinetics, and histamine 2 receptor antagonists are effective for the treatment of FD. Mucosal protecting agents, fundus relaxant, and drugs for visceral hypersensitivity can improve symptoms in FD. Antacids and antidepressants may help improving symptoms in FD. Comparing endoscopy with 'test and treat' of Helicobacter pylori, endoscopy may be more effective initial strategy for managing patients with FD in Korea given high incidence of gastric cancer and low cost of endoscopy. Helicobacter pylori eradication can be one of the therapeutic options for patients with FD. Psychotherapy is effective for those who have severe symptoms and refractoriness. Further studies are strongly needed to develop better treatment strategies for Korean patients with FD.
Antacids/therapeutic use
;
Anti-Ulcer Agents/therapeutic use
;
Antidepressive Agents/therapeutic use
;
Dyspepsia/diet therapy/*therapy
;
Gastroscopy
;
Helicobacter Infections/drug therapy
;
Helicobacter pylori
;
Histamine H2 Antagonists/therapeutic use
;
Humans
;
Proton Pump Inhibitors/therapeutic use
;
Psychotherapy
;
Serotonin 5-HT3 Receptor Antagonists/therapeutic use
;
Vasoconstrictor Agents/therapeutic use
10.A Case of Prothionamide Induced Hepatitis on Patient with Multi-Drug Resistant Pulmonary Tuberculosis.
Jun Beom PARK ; Byung Hoon PARK ; Ji Young SON ; Ji Ye JUNG ; Eun Young KIM ; Ju Eun LIM ; Sang Hoon LEE ; Sang Kook LEE ; Song Yee KIM ; Wonjai JUNG ; Seungtaek LIM ; Kyung Jong LEE ; Young Ae KANG ; Young Sam KIM ; Se Kyu KIM ; Joon CHANG ; Junjeong CHOI ; Moo Suk PARK
Tuberculosis and Respiratory Diseases 2011;70(3):251-256
The prevalence of multi-drug resistant tuberculosis (MDR-TB), which is resistant to isoniazid and rifampin, has been increasing in Korea. And the side effects of 2nd line anti-tuberculosis medications, including drug-induced hepatitis, are well known. Although prothionamide (PTH) is one of the most useful anti-TB medications and although TB medication-induced acute hepatitis is a severe complication, there are only a few published case reports about prothionamide induced hepatitis. In this case report, a 22 year old male was diagnosed with pulmonary MDR-TB and was administered 2nd line anti-TB mediations, including PTH. Afterwards, he had a spiking fever and his liver enzymes were more than 5 times greater than the upper limit of the normal range. He was then diagnosed with drug-induced hepatitis by liver biopsy. His symptoms and liver enzyme elevation were improved after stopping PTH. Accordingly, we report this case of an association between PTH and acute hepatitis.
Biopsy
;
Drug-Induced Liver Injury
;
Fever
;
Hepatitis
;
Humans
;
Isoniazid
;
Korea
;
Liver
;
Male
;
Prevalence
;
Prothionamide
;
Reference Values
;
Rifampin
;
Tuberculosis, Multidrug-Resistant
;
Tuberculosis, Pulmonary

Result Analysis
Print
Save
E-mail